Loading...
Market
What will Summit Therapeutics' stock price be at the end of Q1 2024?
2
Resolution / Starting Odds
Below $20 per share • 25%
$20-$24.99 per share • 25%
$25-$29.99 per share • 25%
$30 or above per share • 25%
Publicly available stock market data from financial news websites or stock exchanges
Story
Summit Therapeutics Raises $235M in Private Placement, Market Cap at $18.7B
Sep 12, 2024, 12:44 PM
Summit Therapeutics has raised $235 million through a private placement, issuing 10.35 million shares at $22.70 per share. Of the total amount, $79 million was raised by insiders, with the remaining $156 million coming from multiple leading biopharma institutional investors. The company's market capitalization is approximately $18.7 billion. This fundraising effort follows the company's strong pricing and substantial insider participation, reflecting confidence in its future prospects. The raise was also influenced by significant lung cancer data.
View original story
Similar markets
Yes • 50%
No • 50%
Less than $500 million • 25%
$500 million to $1 billion • 25%
$1 billion to $1.5 billion • 25%
More than $1.5 billion • 25%
Above $40 • 25%
Between $30 and $40 • 25%
Between $20 and $30 • 25%
Below $20 • 25%
Below $60 • 25%
$60-$70 • 25%
$70-$80 • 25%
Above $80 • 25%
Below $2 • 25%
$2 to $5 • 25%
Above $10 • 25%
Below $5 • 25%
$5 to $10 • 25%
$10 to $15 • 25%
Above $15 • 25%
Below $20 • 25%
$20 to $40 • 25%
$40 to $60 • 25%
Above $60 • 25%
Decrease by more than 10% • 25%
Change between -10% and 10% • 25%
Increase by 10% to 20% • 25%
Increase by more than 20% • 25%
Below $150 • 33%
$150 - $200 • 33%
Above $200 • 33%
Below $30 • 25%
$30-$40 • 25%
$40-$50 • 25%
Above $50 • 25%
Below $50 • 25%
$50 to $75 • 25%
$75 to $100 • 25%
Above $100 • 25%
Less than 50% • 25%
50% to 100% • 25%
100% to 200% • 25%
More than 200% • 25%
Above $50 • 25%
$30 to $50 • 25%
$10 to $30 • 25%
Below $10 • 25%